BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:23 PM
 | 
Oct 08, 2009
 |  BC Extra  |  Politics & Policy

FDA to review cancer accelerated approvals

FDA's Office of Oncology Drug Products is launching a review of drugs that have received accelerated approval for oncology indications, ODP Director Richard Pazdur said Thursday...

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >